《港股開市》恆指低開272點 阿裏巴巴及京東受壓
美股道指上週五(21日)跌450點或1.3%,納指跌2.7%。港股早市隨外圍低開。恆指低開272點或1.09%,報24,693點;國指低開105點或1.2%,報8,682點;恆生科技指數低開120點或2.06%,報5,749點。
匯控(00005.HK)低開1.1%報52.65元。港交所(00388.HK)高開0.3%,友邦(01299.HK)低開0.9%。人社部等再對騰訊(00700.HK)、阿裏(09988.HK)及美團(03690.HK)等平臺行政指導,騰訊低開1%報470元,阿裏巴巴低開4%報122元,美團(03690.HK)低開2%報233.2元。
其他科技股方面,小米(01810.HK)低開1.3%,京東(09618.HK)低開5.3%報290元,百度(09888.HK)低開2.5%,網易(09999.HK)低開6.1%報152.4元,嗶哩嗶哩(09626.HK)低開7.6%報285.2元,快手(01024.HK)低開2.4%。商湯(00020.HK)超額配股權獲悉數行使,額外淨籌約8.5億元,股價低開2.4%報6.99元。
內房股雅居樂(03383.HK)逾18億人幣向中海外(00688.HK)售廣州亞運城項目權益,中海外低開0.9%報23.25元,雅居樂高開0.5%報4.23元。世茂(00813.HK)售上海未開發土地變現近11億人民幣,股價低開0.8%報6.11元。
長汽(02333.HK)料按內地會計準則去年純利增逾26%,股價低開3.8%報24元。
據報Vodafone近期研究收購長和(00001.HK)旗下電訊商3英國,長和平開報55.75元。中移動(00941.HK)母企擬今年斥最多50億人幣增持A股,股價低開0.1%報51.2元。復星醫藥(02196.HK)稱口服新冠藥「Molnupiravir」臨牀數據有限,尚未開始生產,股價高開0.4%報36.65元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.